Generics 59

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Imipenem manufacturers

59 products found

Filters

59 products found

imipenem + cilastatin

Powder for solution for injection 500 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

imipenem + cilastatin

Solution for infusion 500 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

imipenem + cilastatin

Solution for injection 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

imipenem + cilastatin

Powder for solution for injection 500 mg + 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
Dossier availability date: Q1 2024, RMS: PT
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

imipenem + cilastatin

Powder for solution for injection 500 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

imipenem + cilastatin

Powder for solution for injection 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

imipenem + cilastatin

Powder for solution for injection/infusion 500 mg+500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
In-licensing
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

imipenem

Solution for injection 250 mg, 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #18884

Manufacturer usually replies in 1 days

imipenem + cilastatin

Vials, injection 500mg + 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Thailand
GMP approvals
PICS
Manufacturer #14397
A pharmaceutical manufacturer based in Asia that has been active in Asia and the Middle East for 40+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, and nutraceuticals. The main therapeutic area includes the cardiovascular system, CNS, and anti-infec'tives.

Manufacturer usually replies in 3 days

imipenem + cilastatin

Solution for injection 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

imipenem + cilastatin

Vials, lyophilized injection 500mg+500mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
MAs for sale
Ukraine
Manufacturer #16118
The pharmaceutical plant follows the European standard throughout the plant. The core belief of the plant is to make sure that the customer receives the best pharmaceutical benefits as well as the intended patient care services.

Manufacturer usually replies in 7 days

imipenem + cilastatin

Powder for solution for injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17903
The company was founded in the 1990s. They manufacture generic pharmaceutical products, supplying the public and private institutions through bidding and direct sales. They manufacture and market more than 50 medicines, assuming the commitments of excellence, traceability, and quality.

Manufacturer usually replies in 1 days

imipenem + cilastatin

Injection 1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #1027

Manufacturer usually replies in 4 days

imipenem + cilastatin sodium

Vials, injection 0.5g + 0.5g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #16160

Manufacturer usually replies in 4 days

imipenem + cilastatin

Solution for injection 500mg+500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Manufacturer #1274

Manufacturer usually replies in 3 days

imipenem + cilastatin

Injection 500 mg/1 g

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
WHO
Manufacturer #963

Manufacturer usually replies in 5 days

imipenem + cilastatin

Injection 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

imipenem + cilastatin

Solution for injection 500mg/1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #13622

Manufacturer usually replies in 6 days

imipenem + cilastatin sodium

Injection 250 mg + 250 mg, 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

Manufacturer usually replies in 6 days

imipenem + cilastatin

Vials, injection 500 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Uruguay
GMP approvals
WHO
Manufacturer #18930
With a history of more than 80 years, they occupy an outstanding place in the market, being one of the main manufacturers of liquid injectables, deferred vehicle powder injectables, and tablets. They have a product line of more than 160 products.

Manufacturer usually replies in 7 days

Want to view all 59 products? Create your free account today!

Imipenem Manufacturers

Imipenem is a potent antibiotic used to treat a wide spectrum of bacterial infections, including but not limited to pneumonia, sepsis, joint infections, intra-abdominal infections, and urinary tract infections. Imipenem manufacturers almost always produce the drug in combination with cilastatin. Suppliers of imipenem/cilastatin medications market them in the form of powders for solution for intravenous injection. Alternatives to imipenem include similar potent antibiotics such as meropenem and ertapenem. The developer and earliest manufacturer of imipenem was Merck, which first introduced the drug into the market in 1987. It has since then become included in the WHO’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Other manufacturers and suppliers have also joined the market with their formulations, the largest of which being. Currently, the largest manufacturers of imipenem/cilastatin medications globally are Savior Lifetec, Sun Pharmaceutical Industries, and Kopran. Imipenem/cilastatin suppliers and distributors market both generic and trade name formulations of the drug.

How Does Imipenem Work?

Imipenem functions as an antibiotic by preventing different gram-positive and gram-negative bacteria from synthesising cell walls. By attaching to penicillin-binding proteins, gram-negative bateria are prevented from synthesising cell walls (PBPs). Iripenem has demonstrated to have the highest affinity for PBP-2, PBP-1a, and PBP-1b in E. coli and specific strains of P. aeruginosa. By inhibiting PBPs, the bacterial cell is unable to add to the peptidoglycan polymer that makes up the bacterial cell wall, ultimately resulting in cell death. Imipenem must be supplied parenterally since it cannot be adequately absorbed through the digestive system.

Wholesale Price of Imipenem

Imipenem is available for sale from various Imipenem vendors at multiple costs. The retail prices for 10 sachets of 500mg + 500mg imipenem/cilastatin powders fall into an approximate range of 50 EUR to 100 EUR. However, the price of Imipenem is higher than that of such substitutes, owing largely to the more costly manufacturing process needed to produce it. Also, the costs of Imipenem vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. It is available or sale at every medical store. Imipenem suppliers, on the whole, are in favor of patient aid initiatives.

From Where to Get Imipenem?

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified imipenem manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Buyers are advised to buy from PipelinePharma. Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Imipenem manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Imipenem can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Imipenem suppliers or manufacturers. You may also use filters to narrow down your search results and look for Imipenem from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Imipenem offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Imipenem suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Imipenem. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Imipenem is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Imipenem suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Imipenem manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.